Anti-phospholipid antibodies (aPL) and apoptosis: Prothrombin-dependent aPL as a paradigm for phospholipid-dependent interactions with apoptotic cells

Thrombosis Research

Volumn 114, Issue 5-6 SPEC. ISS., 2004, Pages 371-382

  Rauch, Joyce ^a   D'Agnillo, Paolo ^a   Subang, Rebecca ^a   Levine, Jerrold S ^b  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Anti phospholipid antibodies; Apoptotic cells; beta; 2 glycoprotein I; Lupus anticoagulant antibodies; Prothrombin; Systemic lupus erythematosus

Indexed keywords

CHORIONIC GONADOTROPIN; GLYCOPROTEIN IIB; MONOCLONAL ANTIBODY; PHOSPHOLIPID; PHOSPHOLIPID ANTIBODY; PROTHROMBIN;

ANTIBODY AFFINITY; APOPTOSIS; CELL ACTIVATION; CONFERENCE PAPER; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION;

ANIMALS; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIBODIES, MONOCLONAL; ANTICOAGULANTS; ANTIGENS; APOPTOSIS; BETA 2-GLYCOPROTEIN I; BINDING SITES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULIN G; LUPUS; MICE; PHOSPHOLIPIDS; PROTEIN BINDING; PROTHROMBIN;

EID: 7044234652     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2004.08.007     Document Type: Conference Paper

References (42)

1. E.N. Harris, A.E. Gharavi, M.L. Boey, B.M. Patel, C.G. Mackworth-Young, and S. Loizou Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus Lancet 2 1983 1211 1214
2. J.S. Levine, D.W. Branch, and J. Rauch The antiphospholipid syndrome N. Engl. J. Med. 346 2002 752 763
3. R.A.S. Roubey Immunology of the antiphospholipid antibody syndrome Arthritis Rheum. 39 1996 1444 1454
4. H.P. McNeil, R.J. Simpson, C.N. Chesterman, and S.A. Krilis Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: β2-glycoprotein I (apolipoprotein H) Proc. Natl. Acad. Sci. U. S. A. 87 1990 4120 4124
5. M. Galli, P. Comfurius, C. Maassen, H.C. Hemker, M.H. De Baets, and P.J.C. van Breda-Vriesman Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor Lancet 335 1990 1544 1547
6. A. Loeliger Prothrombin as co-factor of the circulating anticoagulant in systemic lupus erythematosus? Thromb. Diath. Haemorrh. 3 1959 237 256
7. E.M. Bevers, M. Galli, M. Barbui, P. Comfurius, and R.F.A. Zwaal Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin Thromb. Haemost. 66 1991 629 632
8. J. Matsuda, N. Saitoh, K. Gohchi, M. Gotoh, and M. Tsukamoto Anti-annexin V antibody in systemic lupus erythematosus patients with lupus anticoagulant and/or anticardiolipin antibody Am. J. Hematol. 47 1994 56 58
9. S. Hörkkö, E. Miller, D.W. Branch, W. Palinski, and J.L. Witztum The epitopes for some antiphospholipid antibodies are adducts of oxidized phospholipid and β2 glycoprotein I (and other proteins) Proc. Natl. Acad. Sci. U. S. A. 94 1997 10356 10361
10. M. Galli, G. Beretta, M. Daldossi, E.M. Bevers, and T. Barbui Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies Thromb. Haemost. 77 1997 486 491
11. J. Rauch, M. Tannenbaum, C. Neville, and P.R. Fortin Inhibition of lupus anticoagulant activity by hexagonal phase phosphatidylethanolamine in the presence of prothrombin Thromb. Haemost. 80 1998 936 941
12. E.J.W. Bowie, J.H. Thompson, C.A. Pascuzzi, and C.A. Owen Thrombosis in systemic lupus erythematosus despite circulating anticoagulants J. Lab. Clin. Med. 62 1963 416 430
13. 2-glycoprotein I J. Clin. Invest. 90 1992 1100 1104
14. R.A. Fleck, S.I. Rapaport, and L.V.M. Rao Anti-prothrombin antibodies and the lupus anticoagulant Blood 72 1988 512 519
15. W. Emlen, J. Niebur, and R. Kadera Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus J. Immunol. 152 1994 3685 3692
16. M. Herrmann, R.E. Voll, O.M. Zoller, M. Hagenhofer, B.B. Ponner, and J.R. Kalden Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus Arthritis Rheum. 41 1998 1241 1250
17. A. Ronchetti, P. Rovere, G. Iezzi, G. Galati, S. Heltai, and M.P. Protti Immunogenicity of apoptotic cells in vivo: role of antigen load, antigen-presenting cells, and cytokines J. Immunol. 163 1999 130 136
18. L.A. Casciola-Rosen, G. Anhalt, and A. Rosen Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes J. Exp. Med. 179 1994 1317 1330
19. L.A. Casciola-Rosen, D.K. Miller, G.J. Anhalt, and A. Rosen Specific cleavage of the 70 kDa protein component of the U1 small nuclear riboprotein is a characteristic biochemical feature of apoptotic cell death J. Biol. Chem. 269 1994 30757 30760
20. L.A. Casciola-Rosen, F. Andrade, D. Ulanet, W. Bang Wong, and A. Rosen Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity J. Exp. Med. 190 1999 815 826
21. P.J. Utz, M. Hottelet, P.H. Schur, and P. Anderson Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus J. Exp. Med. 185 1997 843 854
22. T. Rudel, and G.M. Bokoch Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2 Science 276 1997 1571 1574
23. M. van Engeland, H.J.H. Kuijpers, F.C.A. Ramaekers, C.P.M. Reutelingsperger, and B. Schutte Plasma membrane alterations and cytoskeletal changes in apoptosis Exp. Cell Res. 235 1997 421 430
24. M. Sorice, A. Circella, R. Misasi, V. Pittoni, T. Garofalo, and A. Cirelli Cardiolipin on the surface of apoptotic cells as a possible trigger for anti-phospholipid antibodies Clin. Exp. Immunol. 122 2000 277 284
25. B.E. Price, J. Rauch, M.A. Shia, M.T. Walsh, W. Lieberthal, and H.M. Gilligan Anti-phospholipid autoantibodies bind to apoptotic, but not viable, thymocytes in a β2-glycoprotein I-dependent manner J. Immunol. 157 1996 2201 2208
26. J.S. Levine, R. Subang, J.S. Koh, and J. Rauch Induction of anti-phospholipid autoantibodies by β2-glycoprotein I bound to apoptotic thymocytes J. Autoimmun. 11 1998 413 424
27. P. D'Agnillo, J.S. Levine, R. Subang, and J. Rauch Prothrombin binds to the surface of apoptotic, but not viable, cells and serves as a target of lupus anticoagulant autoantibodies J. Immunol. 170 2003 3408 3422
28. C.A. Janeway P. Travers M. Walport M. Shlomchick Immunobiology The Immune System in Health and Disease 2001 Garland Publishing New York 618
29. J.R. Wu, and B.R. Lentz Phospholipid-specific conformational changes in human prothrombin upon binding to procoagulant acidic lipid membranes Thromb. Haemost. 71 1994 596 604
30. T. Atsumi, M. Ieko, M.L. Bertolaccini, K. Ichikawa, A. Tsutsumi, and E. Matsuura Association of autoantibodies against the phosphatidylserine- prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant Arthritis Rheum. 43 2000 1982 1993
31. P.G. de Groot, and R.H.W.M. Derksen Specificity and clinical relevance of lupus anticoagulant Vessels 1 1995 22 26
32. S.L. Field, C.N. Chesterman, Y.-P. Dai, and P.J. Hogg Lupus antibody bivalency is required to enhance prothrombin binding to phospholipid J. Immunol. 166 2001 6118 6125
33. L.V.M. Rao, A.D. Hoang, and S.I. Rapaport Mechanism and effects of the binding of lupus anticoagulant IgG and prothrombin to surface phospholipid Blood 88 1996 4173 4182
34. M.J.A. Simmelink, D.A. Horbach, R.H.W.M. Derksen, J.C.M. Meijers, E.M. Bevers, and G.M. Willems Complexes of anti-prothrombin antibodies and prothrombin cause lupus anticoagulant activity by competing with the binding of clotting factors for catalytic phospholipid surfaces Br. J. Haematol. 113 2001 621 629
35. Y. Zhao, R. Rumold, M. Zhu, D. Zhou, A.E. Ahmed, and D.T. Le An IgG antiprothrombin antibody enhances prothrombin binding to damaged endothelial cells and shortens plasma coagulation times Arthritis Rheum. 42 1999 2132 2138
36. 2-glycoprotein I complexes to lipid membranes Biochemistry 35 1996 13833 13842
37. H. Takeya, T. Mori, E.C. Gabazza, K. Kuroda, H. Deguchi, and E. Matsuura Anti-β2-glycoprotein I (β2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the β2GPI binding to phospholipids J. Clin. Invest. 99 1997 2260 2268
38. J. Arnout, C. Wittevrongel, M. Vanrusselt, M. Hoylaerts, and J. Vermylen Beta-2-glycoprotein I dependent lupus anticoagulants form stable bivalent antibody beta-2-glycoprotein I complexes on phospholipid surfaces Thromb. Haemost. 79 1998 79 86
39. 2-glycoprotein I binding to phospholipid membranes Thromb. Haemost. 80 1998 610 614
40. 2-glycoprotein I antibody complexes J. Biol. Chem. 276 2001 3060 3067
41. 2-glycoprotein I antibody affinity J. Immunol. 161 1998 2038 2043
42. L. Casciola-Rosen, A. Rosen, M. Petri, and M. Schlissel Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus Proc. Natl. Acad. Sci. U. S. A. 93 1996 1624 1629